{"entity":{"type":"insider","cik":"0001657720","url":"/insider/0001657720","json_url":"/insider/0001657720.json","name":"Deschatelets Pascal","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":50,"n_filings":40,"first":"2019-09-25","last":"2026-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Deschatelets Pascal","source":"filing","n_filings":40,"first_seen":"2019-09-25","last_seen":"2026-01-23"}],"transactions":[{"id":6038548,"accession":"0001492422-26-000058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000058","line_url":"/filing/0001492422-26-000058#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5928.0,"shares_display":"5,928","price_per_share":21.7654,"price_display":"21.77","price_state":"stated","total_value":129025.2912,"total_display":"129,025.29","total_whole":"129,025","shares_owned_after":1151382.0,"shares_owned_after_display":"1,151,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":5932624,"accession":"0001492422-26-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000042","line_url":"/filing/0001492422-26-000042#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":909.0,"shares_display":"909","price_per_share":19.7929,"price_display":"19.79","price_state":"stated","total_value":17991.7461,"total_display":"17,991.75","total_whole":"17,992","shares_owned_after":1157310.0,"shares_owned_after_display":"1,157,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-21","scope":"insider"},{"id":5871316,"accession":"0001492422-26-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000029","line_url":"/filing/0001492422-26-000029#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2277.0,"shares_display":"2,277","price_per_share":22.1872,"price_display":"22.19","price_state":"stated","total_value":50520.2544,"total_display":"50,520.25","total_whole":"50,520","shares_owned_after":1158219.0,"shares_owned_after_display":"1,158,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider"},{"id":5163966,"accession":"0001127602-25-002377","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-002377","line_url":"/filing/0001127602-25-002377#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":826.0,"shares_display":"826","price_per_share":29.5236,"price_display":"29.52","price_state":"stated","total_value":24386.4936,"total_display":"24,386.49","total_whole":"24,386","shares_owned_after":1147716.0,"shares_owned_after_display":"1,147,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-01-30","scope":"insider"},{"id":4594266,"accession":"0001127602-25-001833","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001833","line_url":"/filing/0001127602-25-001833#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3948.0,"shares_display":"3,948","price_per_share":30.4255,"price_display":"30.43","price_state":"stated","total_value":120119.874,"total_display":"120,119.87","total_whole":"120,120","shares_owned_after":1148542.0,"shares_owned_after_display":"1,148,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":4765344,"accession":"0001127602-25-001618","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001618","line_url":"/filing/0001127602-25-001618#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":29.9582,"price_display":"29.96","price_state":"stated","total_value":22468.65,"total_display":"22,468.65","total_whole":"22,469","shares_owned_after":1137445.0,"shares_owned_after_display":"1,137,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-21","scope":"insider"},{"id":4510975,"accession":"0001127602-25-001189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001189","line_url":"/filing/0001127602-25-001189#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2288.0,"shares_display":"2,288","price_per_share":28.7021,"price_display":"28.70","price_state":"stated","total_value":65670.4048,"total_display":"65,670.40","total_whole":"65,670","shares_owned_after":1138195.0,"shares_owned_after_display":"1,138,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-14","scope":"insider"},{"id":2625493,"accession":"0001127602-24-014811","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-24-014811","line_url":"/filing/0001127602-24-014811","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78907.0,"shares_display":"78,907","price_per_share":42.35173067028274,"price_display":"42.35","price_state":"stated","total_value":3341848.012,"total_display":"3,341,848.01","total_whole":"3,341,848","shares_owned_after":1138555.0,"shares_owned_after_display":"1,138,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-08","filed_date":"2024-05-09","scope":"insider","n_lines":3},{"id":2087314,"accession":"0001127602-24-012710","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-24-012710","line_url":"/filing/0001127602-24-012710","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69107.0,"shares_display":"69,107","price_per_share":54.17114357590403,"price_display":"54.17","price_state":"stated","total_value":3743605.2191,"total_display":"3,743,605.22","total_whole":"3,743,605","shares_owned_after":1120711.0,"shares_owned_after_display":"1,120,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-08","filed_date":"2024-04-09","scope":"insider","n_lines":2},{"id":2307783,"accession":"0001127602-24-009368","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-24-009368","line_url":"/filing/0001127602-24-009368","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69107.0,"shares_display":"69,107","price_per_share":62.18688667139364,"price_display":"62.19","price_state":"stated","total_value":4297549.1772,"total_display":"4,297,549.18","total_whole":"4,297,549","shares_owned_after":1142340.0,"shares_owned_after_display":"1,142,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-11","scope":"insider","n_lines":3},{"id":2052498,"accession":"0001127602-24-004716","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-004716","line_url":"/filing/0001127602-24-004716#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1148.0,"shares_display":"1,148","price_per_share":67.7669,"price_display":"67.77","price_state":"stated","total_value":77796.4012,"total_display":"77,796.40","total_whole":"77,796","shares_owned_after":1115983.0,"shares_owned_after_display":"1,115,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":2306912,"accession":"0001127602-24-002736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-002736","line_url":"/filing/0001127602-24-002736#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":874.0,"shares_display":"874","price_per_share":64.1382,"price_display":"64.14","price_state":"stated","total_value":56056.7868,"total_display":"56,056.79","total_whole":"56,057","shares_owned_after":1117131.0,"shares_owned_after_display":"1,117,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":2999099,"accession":"0001127602-24-001937","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-001937","line_url":"/filing/0001127602-24-001937#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3913.0,"shares_display":"3,913","price_per_share":64.996,"price_display":"65.00","price_state":"stated","total_value":254329.348,"total_display":"254,329.35","total_whole":"254,329","shares_owned_after":1118005.0,"shares_owned_after_display":"1,118,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-23","scope":"insider"},{"id":3067586,"accession":"0001127602-24-001443","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-001443","line_url":"/filing/0001127602-24-001443#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1632.0,"shares_display":"1,632","price_per_share":66.8086,"price_display":"66.81","price_state":"stated","total_value":109031.6352,"total_display":"109,031.64","total_whole":"109,032","shares_owned_after":1121918.0,"shares_owned_after_display":"1,121,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-17","scope":"insider"},{"id":8699814,"accession":"0001127602-23-027092","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-027092","line_url":"/filing/0001127602-23-027092#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":47.27,"price_display":"47.27","price_state":"stated","total_value":567240.0,"total_display":"567,240.00","total_whole":"567,240","shares_owned_after":1071807.0,"shares_owned_after_display":"1,071,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-08","filed_date":"2023-11-09","scope":"insider"},{"id":8625474,"accession":"0001127602-23-025708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-025708","line_url":"/filing/0001127602-23-025708#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":40.38,"price_display":"40.38","price_state":"stated","total_value":484560.0,"total_display":"484,560.00","total_whole":"484,560","shares_owned_after":1066313.0,"shares_owned_after_display":"1,066,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-09","filed_date":"2023-10-10","scope":"insider"},{"id":8293424,"accession":"0001127602-23-023970","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-023970","line_url":"/filing/0001127602-23-023970#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":42.87,"price_display":"42.87","price_state":"stated","total_value":514440.0,"total_display":"514,440.00","total_whole":"514,440","shares_owned_after":1059813.0,"shares_owned_after_display":"1,059,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-08","filed_date":"2023-09-11","scope":"insider"},{"id":8227686,"accession":"0001127602-23-022231","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-022231","line_url":"/filing/0001127602-23-022231#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":23.66,"price_display":"23.66","price_state":"stated","total_value":283920.0,"total_display":"283,920.00","total_whole":"283,920","shares_owned_after":1053313.0,"shares_owned_after_display":"1,053,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-08","filed_date":"2023-08-09","scope":"insider"},{"id":8075705,"accession":"0001127602-23-020575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-020575","line_url":"/filing/0001127602-23-020575#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":84.55,"price_display":"84.55","price_state":"stated","total_value":1014600.0,"total_display":"1,014,600.00","total_whole":"1,014,600","shares_owned_after":1046813.0,"shares_owned_after_display":"1,046,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-11","scope":"insider"},{"id":8205634,"accession":"0001127602-23-018441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-018441","line_url":"/filing/0001127602-23-018441#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":91.35,"price_display":"91.35","price_state":"stated","total_value":1096200.0,"total_display":"1,096,200.00","total_whole":"1,096,200","shares_owned_after":1040313.0,"shares_owned_after_display":"1,040,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-09","scope":"insider"},{"id":8120767,"accession":"0001127602-23-015029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-015029","line_url":"/filing/0001127602-23-015029#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":92.39,"price_display":"92.39","price_state":"stated","total_value":1108680.0,"total_display":"1,108,680.00","total_whole":"1,108,680","shares_owned_after":1033813.0,"shares_owned_after_display":"1,033,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-08","filed_date":"2023-05-09","scope":"insider"},{"id":7946096,"accession":"0001127602-23-012801","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-012801","line_url":"/filing/0001127602-23-012801#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":78.21,"price_display":"78.21","price_state":"stated","total_value":938520.0,"total_display":"938,520.00","total_whole":"938,520","shares_owned_after":1027313.0,"shares_owned_after_display":"1,027,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-10","filed_date":"2023-04-11","scope":"insider"},{"id":8475045,"accession":"0001127602-23-009781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-009781","line_url":"/filing/0001127602-23-009781#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":63.79,"price_display":"63.79","price_state":"stated","total_value":765480.0,"total_display":"765,480.00","total_whole":"765,480","shares_owned_after":1020813.0,"shares_owned_after_display":"1,020,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-08","filed_date":"2023-03-10","scope":"insider"},{"id":7925918,"accession":"0001127602-23-004506","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-004506","line_url":"/filing/0001127602-23-004506#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":54.45,"price_display":"54.45","price_state":"stated","total_value":653400.0,"total_display":"653,400.00","total_whole":"653,400","shares_owned_after":1006756.0,"shares_owned_after_display":"1,006,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-10","scope":"insider"},{"id":8411848,"accession":"0001127602-23-001255","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-001255","line_url":"/filing/0001127602-23-001255#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":46.08,"price_display":"46.08","price_state":"stated","total_value":552960.0,"total_display":"552,960.00","total_whole":"552,960","shares_owned_after":983780.0,"shares_owned_after_display":"983,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-10","scope":"insider"},{"id":6343022,"accession":"0001127602-22-027286","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-027286","line_url":"/filing/0001127602-22-027286#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":47.5,"price_display":"47.50","price_state":"stated","total_value":570000.0,"total_display":"570,000.00","total_whole":"570,000","shares_owned_after":970280.0,"shares_owned_after_display":"970,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2022-12-12","scope":"insider"},{"id":6533642,"accession":"0000899243-22-035477","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-035477","line_url":"/filing/0000899243-22-035477#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":46.47,"price_display":"46.47","price_state":"stated","total_value":557640.0,"total_display":"557,640.00","total_whole":"557,640","shares_owned_after":963780.0,"shares_owned_after_display":"963,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-08","filed_date":"2022-11-10","scope":"insider"},{"id":6993215,"accession":"0001127602-22-023859","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-023859","line_url":"/filing/0001127602-22-023859#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":57.5,"price_display":"57.50","price_state":"stated","total_value":690000.0,"total_display":"690,000.00","total_whole":"690,000","shares_owned_after":957280.0,"shares_owned_after_display":"957,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-10","filed_date":"2022-10-11","scope":"insider"},{"id":6250131,"accession":"0001127602-22-022320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-022320","line_url":"/filing/0001127602-22-022320#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":63.98,"price_display":"63.98","price_state":"stated","total_value":767760.0,"total_display":"767,760.00","total_whole":"767,760","shares_owned_after":950780.0,"shares_owned_after_display":"950,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-12","scope":"insider"},{"id":6682680,"accession":"0001127602-22-020735","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-020735","line_url":"/filing/0001127602-22-020735#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":62.5,"price_display":"62.50","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","total_whole":"750,000","shares_owned_after":944280.0,"shares_owned_after_display":"944,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-09","scope":"insider"},{"id":6720173,"accession":"0001127602-22-019227","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-22-019227","line_url":"/filing/0001127602-22-019227#line-3","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":47.95,"price_display":"47.95","price_state":"stated","total_value":575400.0,"total_display":"575,400.00","total_whole":"575,400","shares_owned_after":937780.0,"shares_owned_after_display":"937,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-08","filed_date":"2022-07-12","scope":"insider"},{"id":6152781,"accession":"0001127602-22-017181","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-22-017181","line_url":"/filing/0001127602-22-017181#line-3","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":44.09,"price_display":"44.09","price_state":"stated","total_value":529080.0,"total_display":"529,080.00","total_whole":"529,080","shares_owned_after":891775.0,"shares_owned_after_display":"891,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-09","scope":"insider"},{"id":6963096,"accession":"0001127602-22-012929","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-22-012929","line_url":"/filing/0001127602-22-012929#line-3","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":44.43,"price_display":"44.43","price_state":"stated","total_value":177720.0,"total_display":"177,720.00","total_whole":"177,720","shares_owned_after":891775.0,"shares_owned_after_display":"891,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-02","scope":"insider"},{"id":5541168,"accession":"0001127602-21-020710","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-020710","line_url":"/filing/0001127602-21-020710#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":65.61,"price_display":"65.61","price_state":"stated","total_value":410062.5,"total_display":"410,062.50","total_whole":"410,063","shares_owned_after":869587.0,"shares_owned_after_display":"869,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-24","filed_date":"2021-06-25","scope":"insider"},{"id":4411570,"accession":"0001127602-21-017979","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-017979","line_url":"/filing/0001127602-21-017979#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":47.4,"price_display":"47.40","price_state":"stated","total_value":296250.0,"total_display":"296,250.00","total_whole":"296,250","shares_owned_after":869587.0,"shares_owned_after_display":"869,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-25","scope":"insider"},{"id":4517204,"accession":"0001127602-21-014489","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-014489","line_url":"/filing/0001127602-21-014489#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":46.13,"price_display":"46.13","price_state":"stated","total_value":288312.5,"total_display":"288,312.50","total_whole":"288,313","shares_owned_after":865087.0,"shares_owned_after_display":"865,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-23","filed_date":"2021-04-26","scope":"insider"},{"id":4624404,"accession":"0001127602-21-010212","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-010212","line_url":"/filing/0001127602-21-010212#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":50.74,"price_display":"50.74","price_state":"stated","total_value":317125.0,"total_display":"317,125.00","total_whole":"317,125","shares_owned_after":865087.0,"shares_owned_after_display":"865,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-11","scope":"insider"},{"id":3329954,"accession":"0001127602-20-005685","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-20-005685","line_url":"/filing/0001127602-20-005685#line-4","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55398.0,"shares_display":"55,398","price_per_share":40.979,"price_display":"40.98","price_state":"stated","total_value":2270154.642,"total_display":"2,270,154.64","total_whole":"2,270,155","shares_owned_after":1008681.0,"shares_owned_after_display":"1,008,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-14","scope":"insider"},{"id":3329945,"accession":"0001127602-20-005685","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-005685","line_url":"/filing/0001127602-20-005685#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52075.0,"shares_display":"52,075","price_per_share":42.803,"price_display":"42.80","price_state":"stated","total_value":2228966.225,"total_display":"2,228,966.22","total_whole":"2,228,966","shares_owned_after":946874.0,"shares_owned_after_display":"946,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-12","filed_date":"2020-02-14","scope":"insider"},{"id":7843977,"accession":"0001127602-19-029139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-19-029139","line_url":"/filing/0001127602-19-029139","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21541.0,"shares_display":"21,541","price_per_share":25.256895594447798,"price_display":"25.26","price_state":"stated","total_value":544058.788,"total_display":"544,058.79","total_whole":"544,059","shares_owned_after":882753.0,"shares_owned_after_display":"882,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-25","filed_date":"2019-09-26","scope":"insider","n_lines":2},{"id":8424104,"accession":"0001127602-19-029087","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-19-029087","line_url":"/filing/0001127602-19-029087","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21602.0,"shares_display":"21,602","price_per_share":24.584799416720674,"price_display":"24.58","price_state":"stated","total_value":531080.837,"total_display":"531,080.84","total_whole":"531,081","shares_owned_after":904579.0,"shares_owned_after_display":"904,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-24","filed_date":"2019-09-25","scope":"insider","n_lines":2},{"id":8424102,"accession":"0001127602-19-029087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-19-029087","line_url":"/filing/0001127602-19-029087","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657720","owner_name":"Deschatelets Pascal","owner_display_name":"Deschatelets Pascal","owner_url":"/insider/0001657720","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20858.0,"shares_display":"20,858","price_per_share":25.07021497746668,"price_display":"25.07","price_state":"stated","total_value":522914.544,"total_display":"522,914.54","total_whole":"522,915","shares_owned_after":924986.0,"shares_owned_after_display":"924,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-25","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":50,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":50,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":50},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Officer (Chief Scientific Officer)","n_filings":40,"first_seen":"2019-09-25","last_seen":"2026-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001657720","retrieved_at":"2026-08-27T10:04:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}